An experimental Alzheimer’s drug shows some promise as researchers hunt new approaches

WASHINGTON (AP) — An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers reported Tuesday. Tau is one part of a toxic duo fueling Alzheimer’s but prior attempts to develop dru...

Redirecting to full article...